Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
ACS Chemical Biology
|
February 9, 2019
New Molecular Scaffolds for Fluorescent Voltage Indicators
Steven C Boggess, Shivaani S Gandhi, Brian A Siemons, et al.
Biotechnology and Bioengineering
|
April 18, 2018
Quantitatively characterizing drug-induced arrhythmic contractile motions of human stem cell-derived cardiomyocytes
Plansky Hoang, Nathaniel Huebsch, Shin Hyuk Bang, et al.
ACS Pharmacology & Translational Science
|
August 19, 2022
Validating the Arrhythmogenic Potential of High-, Intermediate-, and Low-Risk Drugs in a Human-Induced Pluripotent Stem Cell-Derived Cardiac Microphysiological System
Verena Charwat, Bérénice Charrez, Brian A Siemons, et al.
Frontiers in Pharmacology
|
August 23, 2021
Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics
Bérénice Charrez, Verena Charwat, Brian A Siemons, et al.
Journal of Cardiovascular Development and Disease
|
August 27, 2025
Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential
M Iveth Garcia, Bhavya Bhardwaj, Keri Dame, et al.
Nature Protocols
|
April 8, 2025
Human induced pluripotent stem cell-derived cardiomyocytes and their use in a cardiac organ-on-a-chip to assay electrophysiology, calcium and contractility
M Iveth Garcia, Keri Dame, Verena Charwat, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
ACS Chemical Biology
|
February 9, 2019
New Molecular Scaffolds for Fluorescent Voltage Indicators
Steven C Boggess, Shivaani S Gandhi, Brian A Siemons, et al.
Biotechnology and Bioengineering
|
April 18, 2018
Quantitatively characterizing drug-induced arrhythmic contractile motions of human stem cell-derived cardiomyocytes
Plansky Hoang, Nathaniel Huebsch, Shin Hyuk Bang, et al.
ACS Pharmacology & Translational Science
|
August 19, 2022
Validating the Arrhythmogenic Potential of High-, Intermediate-, and Low-Risk Drugs in a Human-Induced Pluripotent Stem Cell-Derived Cardiac Microphysiological System
Verena Charwat, Bérénice Charrez, Brian A Siemons, et al.
Frontiers in Pharmacology
|
August 23, 2021
Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics
Bérénice Charrez, Verena Charwat, Brian A Siemons, et al.
Journal of Cardiovascular Development and Disease
|
August 27, 2025
Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential
M Iveth Garcia, Bhavya Bhardwaj, Keri Dame, et al.
Nature Protocols
|
April 8, 2025
Human induced pluripotent stem cell-derived cardiomyocytes and their use in a cardiac organ-on-a-chip to assay electrophysiology, calcium and contractility
M Iveth Garcia, Keri Dame, Verena Charwat, et al.
Page
of 1